esv3835354
- Organism: Homo sapiens
- Study:estd219 (1000 Genomes Consortium Phase 3 Integrated SV)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:20,433
- Publication(s):1000 Genomes Consortium Phase 3 Integrated SV
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 154 SVs from 35 studies. See in: genome view
Overlapping variant regions from other studies: 154 SVs from 35 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
esv3835354 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000004.12 | Chr4 | 61,342,600 (-400, +400) | 61,363,032 (-400, +400) |
esv3835354 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000004.11 | Chr4 | 62,208,318 (-400, +400) | 62,228,750 (-400, +400) |
Variant Call Information
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
essv18875605 | Remapped | Perfect | NC_000004.12:g.(61 342200_61343000)_( 61362632_61363432) inv | GRCh38.p12 | First Pass | NC_000004.12 | Chr4 | 61,342,600 (-400, +400) | 61,363,032 (-400, +400) |
essv18875605 | Submitted genomic | NC_000004.11:g.(62 207918_62208718)_( 62228350_62229150) inv | GRCh37 (hg19) | NC_000004.11 | Chr4 | 62,208,318 (-400, +400) | 62,228,750 (-400, +400) |